Lévy S, Hilaire J, Albin H, Corbelli J L, Burtey J P, Bricaud H, Gérard R
Br Heart J. 1986 Jun;55(6):569-74. doi: 10.1136/hrt.55.6.569.
Electrophysiological variables were studied in 19 patients before and after one of three commonly used antiarrhythmic agents. The pacing rate at which alternating Wenckebach periods appeared in eight patients was significantly reduced by intravenous digoxin (0.01 mg/kg body weight). The atrioventricular nodal conduction time (A-H interval) and Wenckebach point were not significantly altered by digoxin. Intravenous propranolol (0.1 mg/kg body weight) in four patients did not affect the A-H interval, but it reduced the pacing rates at which the Wenckebach point and alternating Wenckebach periods occurred. Intravenous disopyramide (2 mg/kg body weight) significantly increased the pacing rate required to produce alternating Wenckebach periods but did not significantly alter the other indicators of atrioventricular conduction in seven patients. It is concluded that the pacing rate required to produce alternating Wenckebach periodicity may be a useful and sensitive variable in the evaluation of the effect of antiarrhythmic agents on atrioventricular nodal conduction.
在19名患者中,研究了三种常用抗心律失常药物之一使用前后的电生理变量。静脉注射地高辛(0.01mg/kg体重)后,8名出现交替性文氏周期的患者的起搏频率显著降低。地高辛对房室结传导时间(A-H间期)和文氏点无显著影响。4名患者静脉注射普萘洛尔(0.1mg/kg体重)不影响A-H间期,但降低了出现文氏点和交替性文氏周期的起搏频率。静脉注射丙吡胺(2mg/kg体重)显著提高了产生交替性文氏周期所需的起搏频率,但7名患者的其他房室传导指标无显著变化。结论是,产生交替性文氏周期所需的起搏频率可能是评估抗心律失常药物对房室结传导作用的一个有用且敏感的变量。